← Back
$IOVA All transactions

IOVANCE BIOTHERAPEUTICS, INC.

A

$ Value

$0

Shares

67,546

Price

$0

Filed

Jun 17

Insider

Name

Maynard Ryan D

Title

CIK

0001363984

Roles

Director

Transaction Details

Transaction Date

2025-06-13

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

67,546

Footnotes

Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended). | Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date.

Filing Info

Accession No.

0001104659-25-060253

Form Type

4

Issuer CIK

0001425205

Maynard Ryan D's History

Date Ticker Type Value
2026-02-23 FHTX A $2.3M
2025-06-13 IOVA A $0

Other Insiders at IOVA (90d)

Insider Bought Sold Last
BILINSKY IGOR
Chief Operating Officer
2026-03-09
Vogt Frederick G
Interim CEO & General Counsel
2026-03-09
GRAF FINCKENSTEIN FRIEDRICH
Chief Medical Officer
2026-03-09
Roche Corleen M.
Chief Financial Officer
2026-03-09
Puri Raj K.
Chief Regulatory Officer
2026-03-09
Kirby Daniel Gordon
Chief Commercial Officer
2026-03-09